Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine

AIDS Research and Human Retroviruses

Volumn 17, Issue 15, 2001, Pages 1447-1453

  Mateo, L ^a   Gardner, J ^a   Suhrbier, A ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PLACEBO; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CANCER CONTROL; CATTLE DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOSARCOMA; MUTATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHEEP; VACCINATION; VIREMIA;

ANIMALS; CATTLE; DISEASE PROGRESSION; ENZOOTIC BOVINE LEUKOSIS; EPITOPES, T-LYMPHOCYTE; LEUKEMIA VIRUS, BOVINE; MUTAGENESIS; POLYMERASE CHAIN REACTION; SHEEP; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0034762120     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201753197114     Document Type: Article

References (17)

1. Bovine leukemia virus
2. Lymphosarcoma development in sheep experimentally infected with bovine leukemia virus
3. Experimental transmission of enzootic bovine leukosis to sheep: Latency period of the tumoral disease
4. Bovine leukemia virus, an animal model for the study of intrastrain variability
5. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge
6. Protection of sheep against bovine leukemia virus infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: Correlation of protection with CD4 T-cell response to gp51 peptide 51-70
7. Molecular cloning and sequencing of an Australian isolate of proviral bovine leukemia virus DNA: Comparison with other isolates
8. Experimental transmission of enzootic bovine leukosis to cattle, sheep and goats: Infectious doses of blood and incubation period of the disease
9. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
10. Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses
11. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans
12. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro
13. Viral counts count in HIV infection
14. Ovine cytokines and their role in the immune response
15. An HTLV-I/II vaccine: From animal models to clinical trials
16. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease